Iterum Therapeutics PLC
NASDAQ:ITRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Iterum Therapeutics PLC
NASDAQ:ITRM
|
IE |
|
B
|
Bioventus Inc
NASDAQ:BVS
|
US |
|
Tech Mahindra Ltd
NSE:TECHM
|
IN |
|
H
|
Hargreaves Lansdown PLC
F:DMB
|
UK |
Shareholder Yield
Current shareholder yield for ITRM is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
ITRM Price
Iterum Therapeutics PLC
| Average Annual Return | -10.85% |
| Standard Deviation of Annual Returns | 89.35% |
| Max Drawdown | -100% |
| Market Capitalization | 941.3k USD |
| Shares Outstanding | 21 296 296 |
| Percentage of Shares Shorted | 5.8% |
ITRM Return Decomposition
Main factors of price return
Stock Splits
ITRM's latest stock split occurred on Aug 18, 2022
The company executed a 1-for-15 stock split, meaning that for every 15 shares held, investors received 1 new share.
Before the split, ITRM traded at 0.2221 per share. Afterward, the share price was about 2.9.
The adjusted shares began trading on Aug 18, 2022. This was the only stock split in ITRM's history.
